References
- Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1: 27-31, 1995 https://doi.org/10.1038/nm0195-27
- Jackson, J.R., Seed, M.P., Kircher, C.H., Willoughby, D.A. and Winkler, J.D. The codependence of angiogenesis and chronic inflammation. FASEB J 11: 457-465, 1997 https://doi.org/10.1096/fasebj.11.6.9194526
- Risau, W. Mechanisms of angiogenesis. Nature 386: 671-674, 1997 https://doi.org/10.1038/386671a0
- Emanueli, C. and Madeddu, P. Changing the logic of therapeutic angiogenesis for ischemic disease. Trends Mol Med 11: 207-216, 2005 https://doi.org/10.1016/j.molmed.2005.03.007
- Khurana, R., Simons, M., Martin, J.F. and Zachary, I.C. Role of angiogenesis in cardiovascular disease: a critical appraisal. Circulation 112: 1813-1824, 2005 https://doi.org/10.1161/CIRCULATIONAHA.105.535294
- Timar, J., Dome, B., Fazekas, K., Janovics, A. and Paku, S. Angiogenesis-dependent diseases and angiogenesis therapy. Pathol Oncol Res 7: 85-94, 2001 https://doi.org/10.1007/BF03032573
- Griffith, L.G. and Naughton, G. Tissue engineering--current challenges and expanding opportunities. Science 295: 1009-1014, 2002 https://doi.org/10.1126/science.1069210
- Smith, M.K., Peters, M.C., Richardson, T.P., Garbern, J.C. and Mooney, D.J. Locally enhanced angiogenesis promotes transplanted cell survival. Tissue Eng 10: 63-71, 2004 https://doi.org/10.1089/107632704322791709
- Nomi, M., Atala, A., Coppi, P.D. and Soker, S. Principals of neovascularization for tissue engineering. Mol Aspects Med 23: 463-483, 2002 https://doi.org/10.1016/S0098-2997(02)00008-0
- Simons, M. and Ware, J.A. Therapeutic angiogenesis in cardiovascular disease. Nat Rev Drug Discov 2: 863-871, 2003 https://doi.org/10.1038/nrd1226
- Zisch, A.H., Lutolf, M.P., Ehrbar, M., Raeber, G.P., Rizzi, S.C., Davies, N., Schmokel, H., Bezuidenhout, D., Djonov, V., Zilla, P. and Hubbell, J.A. Cell-demanded release of VEGF from synthetic, biointeractive cell ingrowth matrices for vascularized tissue growth. FASEB J 17: 2260-2262, 2003 https://doi.org/10.1096/fj.02-1041fje
- Attele, A.S., Wu, J.A. and Yuan, C.S. Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol 58: 1685-1693, 1999 https://doi.org/10.1016/S0006-2952(99)00212-9
- Shibata, S. Chemistry and cancer preventing activities of ginseng saponins and some related triterpenoid compounds. J Korean Med Sci 16: S28-37, 2001 https://doi.org/10.3346/jkms.2001.16.S.S28
- Tachikawa, E., Kudo, K., Harada, K., Kashimoto, T., Miyate, Y., Kakizaki, A. and Takahashi, E. Effects of ginseng saponins on responses induced by various receptor stimuli. Eur J Pharmacol 369: 23-32, 1999 https://doi.org/10.1016/S0014-2999(99)00043-6
- Konoshima, T., Takasaki, M., Tokuda, H., Nishino, H., Duc, N. M., Kasai, R. and Yamasaki, K. Anti-tumor-promoting activity of majonoside-R2 from Vietnamese ginseng, Panax vietnamensis Ha et Grushv. (I). Biol Pharm Bull 21: 834-838, 1998 https://doi.org/10.1248/bpb.21.834
- Morisaki, N., Watanabe, S., Tezuka, M., Zenibayashi, M., Shiina, R., Koyama, N., Kanzaki, T. and Saito, Y. Mechanism of angiogenic effects of saponin from ginseng Radix rubra in human umbilical vein endothelial cells. Br J Pharmacol 115: 1188-1193, 1995 https://doi.org/10.1111/j.1476-5381.1995.tb15023.x
- 강병수외. 本草學. 서울, 영림사, p 531, 532, 1991
- 신민교. 臨床本草學. 서울, 영림출판사, p 166, 1989
- 신민교외. 漢藥臨床應用. 서울, 성보사 pp 308-311, 1986
- 김정수. 本草學. 서울, 진명출판사, p 300, 1975
- 신길구. 申氏本草學. 서울, 수문사, pp 2-8, 1982
- 신천호. 問答式本草學. 서울, 영신문화사, p 343, 344, 1992.
- 趙大衍. 東醫寶鑑에 收錄된 紅蔘이 主藥으로 配伍된 方劑의 活用범위, 病証, 主治, 病理 및 構成內容 調査. 원광대학교대학원 2002
- Sengupta, S., Toh, S.A., Sellers, L.A., Skepper, J.N., Koolwijk, P., Leung, H.W., Yeung, H.W., Wong, R.N., Sasisekharan, R. and Fan, T.P. Modulating angiogenesis: the yin and the yang in ginseng. Circulation 110: 1219-1225, 2004 https://doi.org/10.1161/01.CIR.0000140676.88412.CF
- Sato, K., Mochizuki, M., Saiki, I., Yoo, Y.C., Samukawa, K. and Azuma, I. Inhibition of tumor angiogenesis and metastasis by a saponin of Panax ginseng, ginsenoside-Rb2. Biol Pharm Bull 17: 635-639, 1994 https://doi.org/10.1248/bpb.17.635
- Groskopf, J.C., Syu, L.J., Saltiel, A.R. and Linzer, D.I. Proliferin induces endothelial cell chemotaxis through a G protein-coupled, mitogen-activated protein kinase-dependent pathway. Endocrinology 138: 2835-2840, 1997 https://doi.org/10.1210/en.138.7.2835
- Kuzuya, M., Satake, S., Ramos, M.A., Kanda, S., Koike, T., Yoshino, K., Ikeda, S. and Iguchi, A. Induction of apoptotic cell death in vascular endothelial cells cultured in three- dimensional collagen lattice. Exp Cell Res 248: 498-508, 1999 https://doi.org/10.1006/excr.1999.4422
- Lee, O.H., Kim, Y.M., Lee, Y.M., Moon, E.J., Lee, D.J., Kim, J.H., Kim, K.W. and Kwon, Y.G. Sphingosine 1-phosphate induces angiogenesis: its angiogenic action and signaling mechanism in human umbilical vein endothelial cells. Biochem Biophys Res Commun 264: 743-750, 1999 https://doi.org/10.1006/bbrc.1999.1586
- Yu, Y. and Sato, J.D. MAP kinases, phosphatidylinositol 3-kinase, and p70 S6 kinase mediate the mitogenic response of human endothelial cells to vascular endothelial growth factor. J Cell Physiol 178: 235-246, 1999 https://doi.org/10.1002/(SICI)1097-4652(199902)178:2<235::AID-JCP13>3.0.CO;2-S
- Jaffe, E.A., Nachman, R.L., Becker, C.G. and Minick, C.R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 52: 2745-2756, 1973 https://doi.org/10.1172/JCI107470
- Kim, Y.M., Hwang, S., Kim, Y.M., Pyun, B.J., Kim, T.Y., Lee, S.T., Gho, Y.S. and Kwon, Y.G. Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1. J Biol Chem 277: 27872-27879, 2002 https://doi.org/10.1074/jbc.M202771200
- Nicosia, R.F. and Ottinetti, A. Modulation of microvascular growth and morphogenesis by reconstituted basement membrane gel in three-dimensional cultures of rat aorta: a comparative study of angiogenesis in matrigel, collagen, fibrin, and plasma clot. In Vitro Cell Dev Biol 26: 119-128, 1990 https://doi.org/10.1007/BF02624102
- Bussolino, F., Mantovani, A. and Persico, G. Molecular mechanisms of blood vessel formation. Trends Biochem Sci 22: 251-256, 1997 https://doi.org/10.1016/S0968-0004(97)01074-8
- Cheng, Y., Shen, L.H. and Zhang, J.T. Anti-amnestic and anti-aging effects of ginsenoside Rg1 and Rb1 and its mechanism of action. Acta Pharmacol Sin 26: 143-149, 2005 https://doi.org/10.1111/j.1745-7254.2005.00034.x
- Jung, J.D., Park, H.W., Hahn, Y., Hur, C.G., In, D.S., Chung, H.J., Liu, J.R. and Choi, D.W. Discovery of genes for ginsenoside biosynthesis by analysis of ginseng expressed sequence tags. Plant Cell Rep 22: 224-230, 2003 https://doi.org/10.1007/s00299-003-0678-6
- Kaiser, M., Younge, B., Bjornsson, J., Goronzy, J.J. and Weyand, C.M. Formation of new vasa vasorum in vasculitis. Production of angiogenic cytokines by multinucleated giant cells. Am J Pathol 155: 765-774, 1999 https://doi.org/10.1016/S0002-9440(10)65175-9
- Nam, M.H., Kim, S.I., Liu, J.R., Yang, D.C., Lim, Y.P., Kwon, K.H., Yoo, J.S. and Park, Y.M. Proteomic analysis of Korean ginseng (Panax ginseng C.A. Meyer). J Chromatogr B Analyt Technol Biomed Life Sci 815: 147-155, 2005 https://doi.org/10.1016/j.jchromb.2004.10.063
- Yun, T.K., Lee, Y.S., Lee, Y.H., Kim, S.I. and Yun, H.Y. Anticarcinogenic effect of Panax ginseng C.A. Meyer and identification of active compounds. J Korean Med Sci 16: S6-18, 2001 https://doi.org/10.3346/jkms.2001.16.S.S6
- 龔信. 古今醫鑑. 江西, 江西科學技術出版社, p 399, 1990
- 朱震亨. 丹溪心法. 서울, 杏林書院, p 392, 1965
- 李梴. 醫學入門. 서울, 法仁文化社, p 670, 674, 686, 724, 2006
- 陳柱杓. 金元四大家 醫學全書(上). 서울, 法仁文化社, p 793, 855, 2007
- 龔延賢. 萬病回春. 서울, 醫聖堂, p 58, 703, 1993
- 許浚. 東醫寶鑑. 서울, 法仁文化社, p 1415, 1417, 1418, 1425, 1426, 1434, 1435, 1436, 1439, 1454, 1455, 2002
- 黃度淵. 方藥合編. 서울, 南山堂, p 224, 255, 2001
- Roy, H., Bhardwaj, S. and Yla-Herttuala, S. Biology of vascular endothelial growth factors. FEBS Lett 580: 2879-2887, 2006 https://doi.org/10.1016/j.febslet.2006.03.087
- Wieghaus, K.A., Capitosti, S.M., Anderson, C.R., Price, R.J., Blackman, B.R., Brown, M.L. and Botchwey, E.A. Small molecule inducers of angiogenesis for tissue engineering. Tissue Eng 12: 1903-1913, 2006 https://doi.org/10.1089/ten.2006.12.1903
- Goetze, S., Bungenstock, A., Czupalla, C., Eilers, F., Stawowy, P., Kintscher, U., Spencer-Hansch, C., Graf, K., Nurnberg, B., Law, R.E. Leptin induces endothelial cell migration through Akt, which is inhibited by PPARgamma-ligands. Hypertension 40: 748-754, 2002 https://doi.org/10.1161/01.HYP.0000035522.63647.D3
- Qiao, M., Shapiro, P., Kumar, R. and Passaniti, A. Insulin-like growth factor-1 regulates endogenous RUNX2 activity in endothelial cells through a phosphatidylinositol 3-kinase/ERK-dependent and Akt-independent signaling pathway. J Biol Chem 279: 42709-42718, 2004 https://doi.org/10.1074/jbc.M404480200
- Reddy, K.B., Nabha, S.M. and Atanaskova, N. Role of MAP kinase in tumor progression and invasion. Cancer Metastasis Rev 22: 395-403, 2003 https://doi.org/10.1023/A:1023781114568
- Zachary, I. VEGF signalling: integration and multi-tasking in endothelial cell biology. Biochem Soc Trans 31: 1171-1177, 2003 https://doi.org/10.1042/BST0311171
- Li, Z., Zhang, G., Feil, R., Han, J. and Du, X. Sequential activation of p38 and ERK pathways by cGMP-dependent protein kinase leading to activation of the platelet integrin alphaIIb beta3. Blood 107: 965-972, 2006
- Babaei, S., Teichert-Kuliszewska, K., Monge, J.C., Mohamed, F., Bendeck, M.P. and Stewart, D.J. Role of nitric oxide in the angiogenic response in vitro to basic fibroblast growth factor. Circ Res 82: 1007-1015, 1998 https://doi.org/10.1161/01.RES.82.9.1007
- Bussolati, B., Dunk, C., Grohman, M., Kontos, C.D., Mason, J. and Ahmed, A. Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide. Am J Pathol 159: 993-1008, 2001 https://doi.org/10.1016/S0002-9440(10)61775-0